311 related articles for article (PubMed ID: 32910913)
1. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
[TBL] [Abstract][Full Text] [Related]
2. Maturity onset diabetes of the young due to
Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
[TBL] [Abstract][Full Text] [Related]
3. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants.
Malikova J; Kaci A; Dusatkova P; Aukrust I; Torsvik J; Vesela K; Kankova PD; Njølstad PR; Pruhova S; Bjørkhaug L
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32017842
[TBL] [Abstract][Full Text] [Related]
4. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of HNF1A variants in paediatric diabetes in Norway using functional and clinical investigations to unmask phenotype and monogenic diabetes.
Svalastoga P; Kaci A; Molnes J; Solheim MH; Johansson BB; Krogvold L; Skrivarhaug T; Valen E; Johansson S; Molven A; Sagen JV; Søfteland E; Bjørkhaug L; Tjora E; Aukrust I; Njølstad PR
Diabetologia; 2023 Dec; 66(12):2226-2237. PubMed ID: 37798422
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.
Lango Allen H; Johansson S; Ellard S; Shields B; Hertel JK; Raeder H; Colclough K; Molven A; Frayling TM; Njølstad PR; Hattersley AT; Weedon MN
Diabetes; 2010 Jan; 59(1):266-71. PubMed ID: 19794065
[TBL] [Abstract][Full Text] [Related]
7. The Common
Locke JM; Saint-Martin C; Laver TW; Patel KA; Wood AR; Sharp SA; Ellard S; Bellanné-Chantelot C; Hattersley AT; Harries LW; Weedon MN
Diabetes; 2018 Sep; 67(9):1903-1907. PubMed ID: 29895593
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
[TBL] [Abstract][Full Text] [Related]
9. Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.
Breidbart E; Deng L; Lanzano P; Fan X; Guo J; Leibel RL; LeDuc CA; Chung WK
J Pediatr Endocrinol Metab; 2021 May; 34(5):633-638. PubMed ID: 33852230
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and re-interpretation of
Kavitha B; Ranganathan S; Gopi S; Vetrivel U; Hemavathy N; Mohan V; Radha V
Front Endocrinol (Lausanne); 2023; 14():1177268. PubMed ID: 37396188
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T; Skopkova M; Stanik J; Gasperikova D
Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
[TBL] [Abstract][Full Text] [Related]
12. Homozygous Hypomorphic
Misra S; Hassanali N; Bennett AJ; Juszczak A; Caswell R; Colclough K; Valabhji J; Ellard S; Oliver NS; Gloyn AL
Diabetes Care; 2020 Apr; 43(4):909-912. PubMed ID: 32001615
[TBL] [Abstract][Full Text] [Related]
13. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.
Thanabalasingham G; Shah N; Vaxillaire M; Hansen T; Tuomi T; Gašperíková D; Szopa M; Tjora E; James TJ; Kokko P; Loiseleur F; Andersson E; Gaget S; Isomaa B; Nowak N; Raeder H; Stanik J; Njolstad PR; Malecki MT; Klimes I; Groop L; Pedersen O; Froguel P; McCarthy MI; Gloyn AL; Owen KR
Diabetologia; 2011 Nov; 54(11):2801-10. PubMed ID: 21814873
[TBL] [Abstract][Full Text] [Related]
14. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
[TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database.
Awa WL; Thon A; Raile K; Grulich-Henn J; Meissner T; Schober E; Holl RW;
Eur J Endocrinol; 2011 Apr; 164(4):513-20. PubMed ID: 21224407
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India.
Mohan V; Radha V; Nguyen TT; Stawiski EW; Pahuja KB; Goldstein LD; Tom J; Anjana RM; Kong-Beltran M; Bhangale T; Jahnavi S; Chandni R; Gayathri V; George P; Zhang N; Murugan S; Phalke S; Chaudhuri S; Gupta R; Zhang J; Santhosh S; Stinson J; Modrusan Z; Ramprasad VL; Seshagiri S; Peterson AS
BMC Med Genet; 2018 Feb; 19(1):22. PubMed ID: 29439679
[TBL] [Abstract][Full Text] [Related]
17. Mutations in HNF1A result in marked alterations of plasma glycan profile.
Thanabalasingham G; Huffman JE; Kattla JJ; Novokmet M; Rudan I; Gloyn AL; Hayward C; Adamczyk B; Reynolds RM; Muzinic A; Hassanali N; Pucic M; Bennett AJ; Essafi A; Polasek O; Mughal SA; Redzic I; Primorac D; Zgaga L; Kolcic I; Hansen T; Gasperikova D; Tjora E; Strachan MW; Nielsen T; Stanik J; Klimes I; Pedersen OB; Njølstad PR; Wild SH; Gyllensten U; Gornik O; Wilson JF; Hastie ND; Campbell H; McCarthy MI; Rudd PM; Owen KR; Lauc G; Wright AF
Diabetes; 2013 Apr; 62(4):1329-37. PubMed ID: 23274891
[TBL] [Abstract][Full Text] [Related]
18. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
Owen KR; Thanabalasingham G; James TJ; Karpe F; Farmer AJ; McCarthy MI; Gloyn AL
Diabetes Care; 2010 Sep; 33(9):1919-24. PubMed ID: 20724646
[TBL] [Abstract][Full Text] [Related]
19. Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
Jafar-Mohammadi B; Groves CJ; Owen KR; Frayling TM; Hattersley AT; McCarthy MI; Gloyn AL
PLoS One; 2009 Aug; 4(8):e6615. PubMed ID: 19672314
[TBL] [Abstract][Full Text] [Related]
20. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
